Significance of an Early Repeat Troponin Measurement Upon Presentation to the Hospital for Acute Heart Failure

Background Higher cardiac troponin is associated with worse outcomes in patients with acute heart failure. The significance of repeat measurements over hours remains unclear. We assessed whether a repeat measurement and the Delta between measurements of high-sensitivity cardiac troponin I (hs-cTnI)...

Descripción completa

Detalles Bibliográficos
Autores: Horiuchi Y, Maisel AS, van Veldhuisen DJ, Mueller C, Hogan C, Kontos MC, Cannon CM, Müller GA, Taub P, Vilke GM, Duff S, McDonald K, Mahon N, Nuñez J, Briguori C, Passino C, Murray PT, Wettersten N
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2024
País:España
Institución:INCLIVA
Repositorio:r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
OAI Identifier:oai:incliva.fundanetsuite.com:p18675
Acceso en línea:https://incliva.portalinvestigacion.com/publicaciones/18675
Access Level:acceso abierto
Palabra clave:acute heart failure
myocardial injury
prognosis
troponin
Descripción
Sumario:Background Higher cardiac troponin is associated with worse outcomes in patients with acute heart failure. The significance of repeat measurements over hours remains unclear. We assessed whether a repeat measurement and the Delta between measurements of high-sensitivity cardiac troponin I (hs-cTnI) were associated with outcomes in hypervolemic patients with acute heart failure without acute coronary syndrome.Methods and Results We analyzed 582 individuals from AKINESIS (Acute Kidney Injury Neutrophil Gelatinase-Associated Lipocalin Evaluation of Symptomatic Heart Failure Study) with hs-cTnI measured <= 12 hours from admission and repeated <= 6 hours thereafter. Associations between hs-cTnI levels and their Delta with short-term (death, intensive care unit admission, receipt of inotropes, or positive pressure ventilation during hospitalization) and long-term (death or heart failure readmission within 1 year) outcomes were assessed. The average age was 69 +/- 13 years, 62% were men, 65% were White, 46% had coronary artery disease, and 22% had chest pain. Median hs-cTnI levels were 27 (interquartile range [IQR], 13-62) ng/L initially and 28 (IQR, 14-68) ng/L subsequently, with a Delta of 0 [IQR, -2 to 4] ng/L over 3.4 +/- 1 hours. Only the second measurement was associated with short-term outcomes (odds ratio, 1.14 per 2-fold higher [95% CI, 1.02-1.28]). Both individual measurements and the Delta were associated with long-term outcomes (hazard ratios, 1.09, 1.12, and 1.16 for first, second, and Delta, respectively). Associated risk for the first and second measurements were not constant over the year but highest early after being measured and decreased over 1 year.Conclusions Repeat measurements of hs-cTnI over hours can identify individuals with acute heart failure without acute coronary syndrome at risk for short- and long-term outcomes.